CSL, Australia's leading biotechnology company, has appointed Deborah Waterhouse as its new CEO, marking a significant ...

Zydus Lifesciences initiates a Class II recall of Hydrocortisone Sodium Succinate in the US due to impurity and degradation ...

Alkem Laboratories embarks on a forensic audit to investigate alleged fund misappropriation by a former employee, appointing ...

Danaher's CEO highlights the company's strategic position to lead in AI-driven drug discovery, with plans for an AI-powered ...

Explore how cheap Chinese antibiotics threaten the survival of Europe's final major penicillin manufacturing facility in ...

AstraZeneca announces FDA accelerated approval for Ultomiris, a groundbreaking treatment for immunoglobulin A nephropathy, a ...

Abbott Laboratories has announced plans to spin off its nutrition business while cutting its 2026 sales growth forecast amid ...

Sanofi has received approval from CDSCO to market Qfitlia, a hemophilia therapy aimed at preventing bleeding episodes in ...

China's Hansoh Pharmaceutical has partnered with Roche in a groundbreaking licensing deal worth over $15 billion, focusing on ...

Zydus Lifesciences announced FDA approval for Estradiol and Levonorgestrel Transdermal System for menopause treatment, ...

The US FDA approves GSK's Hibsago for chronic hepatitis B, providing patients a chance to control the virus post-treatment.

Dr Reddy's Laboratories receives regulatory approval to use Zytorvi as a first-line treatment for advanced esophageal ...